Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy

Show simple item record

dc.contributor.author Pereira, Patrícia da Silva Fucuta [UNIFESP]
dc.contributor.author Souza e Silva, Ivonete Sandra de [UNIFESP]
dc.contributor.author Uehara, Silvia Naomi de Oliveira [UNIFESP]
dc.contributor.author Emori, Christini Takemi [UNIFESP]
dc.contributor.author Lanzoni, Valeria Pereira [UNIFESP]
dc.contributor.author Silva, Antonio Eduardo Benedito [UNIFESP]
dc.contributor.author Ferraz, Maria Lucia Cardoso Gomes [UNIFESP]
dc.date.accessioned 2015-06-14T13:41:19Z
dc.date.available 2015-06-14T13:41:19Z
dc.date.issued 2009-12-01
dc.identifier http://dx.doi.org/10.1590/S0036-46652009000600004
dc.identifier.citation Revista do Instituto de Medicina Tropical de São Paulo. Instituto de Medicina Tropical, v. 51, n. 6, p. 331-336, 2009.
dc.identifier.issn 0036-4665
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/5405
dc.description.abstract The complex interaction between hepatitis C virus infection, iron homeostasis and the response to antiviral treatment remains controversial. The aim of this study was to evaluate the influence of hepatic iron concentration (HIC) on the sustained virological response (SVR) to antiviral therapy in patients with chronic hepatitis C. A total of 50 patients who underwent pretreatment liver biopsy with assessment of HIC by graphite furnace atomic absorption spectroscopy and were subsequently submitted to antiviral treatment with interferon/peginterferon and ribavirin were included in the study. Patients with alcoholism, history of multiple blood transfusion, chronic kidney disease, hemolytic anemia and parenteral iron therapy were excluded. The iron related markers and HIC were compared between those who achieved an SVR and non-responders (NR) patients. The mean age was 45.7 years and the proportion of patients' gender was not different between SVR and NR patients. The median serum iron was 138 and 134 µg/dL (p = 0.9), the median serum ferritin was 152.5 and 179.5 ng/mL (p = 0.87) and the median HIC was 9.9 and 8.2 µmol/g dry tissue (p = 0.51), for SVR and NR patients, respectively. Thus, hepatic iron concentration, determined by a reliable quantitative method, was not a negative predictive factor of SVR in patients with chronic hepatitis C presenting mild to moderate hepatic iron accumulation. en
dc.description.abstract A complexa interação entre infecção pelo vírus da hepatite C, homeostase do ferro e resposta ao tratamento antiviral permanece controversa. O objetivo deste estudo foi avaliar a influência da concentração hepática de ferro (CHF) na resposta virológica sustentada (RVS) à terapia antiviral na hepatite C crônica. Foram incluídos 50 pacientes que foram submetidos à biopsia hepática pré-tratamento com determinação da CHF por espectrofotometria de absorção atômica com forno de grafite e tratados posteriormente com interferon/peginterferon e ribavirina. Pacientes com alcoolismo, história de múltiplas transfusões sanguíneas, doença renal crônica, anemia hemolítica e terapia com ferro parenteral foram excluídos. O perfil de ferro sérico e a CHF foram comparados entre aqueles que atingiram RVS e os não-respondedores (NR). A média de idade dos pacientes foi 45,7 anos e não houve diferença na proporção de homens e mulheres entre os grupos RVS e NR. A mediana do ferro sérico foi 138 and 134 µg/dL (p = 0.9), a mediana da ferritina sérica foi 152,5 e 179,5 ng/mL (p = 0,87) e a CHF mediana foi 9,9 e 8,2 µmol/g de tecido seco (p = 0,51), para pacientes com RVS e NR, respectivamente. Concluindo, a concentração hepática de ferro, determinada por um método quantitativo confiável, não foi um fator preditivo negativo de RVS em pacientes com hepatite C crônica e acúmulo de ferro hepático leve a moderado. pt
dc.format.extent 331-336
dc.language.iso eng
dc.publisher Instituto de Medicina Tropical
dc.relation.ispartof Revista do Instituto de Medicina Tropical de São Paulo
dc.rights Acesso aberto
dc.subject Iron en
dc.subject Hepatitis C virus en
dc.subject Interferon en
dc.subject Peginterferon en
dc.subject Ribavirin en
dc.subject Liver biopsy en
dc.title Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy en
dc.title.alternative Hepatite C crônica: concentração hepática de ferro não é correlacionada com a resposta ao tratamento antiviral pt
dc.type Artigo
dc.contributor.institution Universidade Federal de São Paulo (UNIFESP)
dc.description.affiliation Federal University of São Paulo Hepatitis Section Division of Gastroenterology
dc.description.affiliation Federal University of São Paulo Department of Pathology
dc.description.affiliationUnifesp UNIFESP, Hepatitis Section Division of Gastroenterology
dc.description.affiliationUnifesp UNIFESP, Department of Pathology
dc.identifier.file S0036-46652009000600004.pdf
dc.identifier.scielo S0036-46652009000600004
dc.identifier.doi 10.1590/S0036-46652009000600004
dc.description.source SciELO



File

Name: S0036-46652009000600004.pdf
Size: 181.4Kb
Format: PDF
Description:
Open file

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account